Stock Screener
US stocks rated by the Lician Quant model: a 1–5 rating and A+ to F grades for valuation, growth, profitability, momentum and EPS revisions, each against the stock’s sector. Filter, sort by any factor and share the URL.
53 stocks · Strong Buy or Buy · Healthcare · EPS Revisions ≥ A-
| Stock | Quant ratingRating | ValuationVal | GrowthGrow | ProfitabilityProf | MomentumMom | EPS revisionsRev | Market capMkt cap | P/EP/E | Revenue growthRev YoY | Div. yieldYield | Short % floatShort | Next earningsEarnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1QTTBQ32 Bio Inc | 5.00Strong Buy | A+ | — | A+ | B | A | $206M | 6.1 | — | — | 57.9% | Nov 12 |
| 2AVAHAveanna Healthcare Holdings Inc | 4.99Strong Buy | A | A- | B+ | A | A+ | $2.9B | 10.6 | +19.5% | — | 10.2% | Nov 12 |
| 3CDNACareDx Inc | 4.98Strong Buy | C+ | B+ | A+ | A+ | A+ | $3.6B | 32.2 | +34.4% | — | 13.6% | — |
| 4HALOHalozyme Therapeutics Inc | 4.97Strong Buy | C | B+ | A+ | A+ | A+ | $14.7B | 35.4 | +41.2% | — | 11.2% | Nov 5 |
| 5REGNRegeneron Pharmaceuticals Inc | 4.95Strong Buy | B+ | C+ | A+ | A | A | $103B | 21.5 | +18.6% | — | 2.1% | — |
| 6ASTHAstrana Health Inc | 4.93Strong Buy | A+ | A | B | C | A+ | $1.8B | 44.0 | +58.9% | — | 8.0% | Nov 5 |
| 7GMEDGlobus Medical | 4.91Strong Buy | A+ | A- | A | C | A- | $8.6B | 16.1 | +19.7% | — | 7.3% | Nov 5 |
| 8HRMYHarmony Biosciences Holdings | 4.91Strong Buy | A+ | B | A | C+ | A- | $2.2B | 12.3 | +24.3% | — | — | Nov 4 |
| 9INVAInnoviva Inc | 4.89Strong Buy | A+ | B+ | A+ | C- | A- | $1.5B | 4.3 | +18.8% | — | 10.5% | Nov 4 |
| 10PTGXProtagonist Therapeutics Inc | 4.88Strong Buy | C | A- | A+ | B+ | A | $9.4B | 113.0 | +34.8% | — | — | Nov 5 |
| 11OMEROmeros Corporation | 4.86Strong Buy | C | — | — | A- | A+ | $1.2B | 9.6 | — | — | 20.4% | Nov 12 |
| 12ADUSAddus HomeCare Corporation | 4.84Strong Buy | A+ | B | B | B | A- | $2.3B | 21.7 | +15.9% | — | — | — |
| 13AMNAMN Healthcare Services Inc | 4.83Strong Buy | A+ | D+ | B- | A+ | A- | $1.6B | 14.9 | +24.0% | — | 10.0% | Nov 5 |
| 14ETONEton Pharmaceuticals Inc | 4.80Strong Buy | D+ | A+ | A- | A- | A- | $1.4B | 113.6 | +81.5% | — | 9.3% | Nov 5 |
| 15PDEXPro-Dex Inc | 4.79Strong Buy | A | A- | B+ | C+ | A- | $184M | 13.4 | +16.5% | — | 13.0% | — |
| 16VRTXVertex Pharmaceuticals Inc | 4.74Strong Buy | B- | C+ | A+ | B | A | $135B | 30.7 | +10.2% | — | 1.7% | — |
| 17DCTHDelcath Systems Inc | 4.73Strong Buy | C+ | A+ | B | B | A- | $499M | 938.8 | +35.8% | — | 6.6% | Nov 9 |
| 18BLCOBausch + Lomb Corp | 4.70Strong Buy | A- | C | B | A- | A | $5.9B | NM | +8.9% | — | — | — |
| 19IQVIQVIA Holdings Inc | 4.68Strong Buy | B+ | C- | A | B+ | A- | $43.1B | 30.9 | +8.8% | — | 1.9% | — |
| 20WSTWest Pharmaceutical Services Inc | 4.66Strong Buy | C+ | C+ | A- | A- | A- | $28.7B | 44.9 | +12.6% | — | 2.8% | — |
| 21ENSGThe Ensign Group Inc | 4.61Strong Buy | A- | B | B | C | A | $10.2B | 27.0 | +18.9% | 0.16% | 2.5% | — |
| 22OPKOpko Health Inc | 4.61Strong Buy | B+ | F | A | A | A+ | $1.3B | 10.8 | -3.8% | — | 9.1% | Nov 4 |
| 23TECHBio-Techne Corp | 4.50Strong Buy | B | C | A- | B- | A | $11.3B | 62.4 | -0.4% | — | 4.9% | Nov 4 |
| 24GRALGRAIL, LLC | 4.48Buy | D+ | A- | D+ | A | A+ | $5.6B | NM | +23.1% | — | 24.4% | Nov 4 |
| 25MTDMettler-Toledo International Inc | 4.42Buy | C+ | D+ | A | A- | A- | $37.0B | 40.8 | +6.9% | — | — | Nov 5 |
Showing 25 of 53
Source: Lician Quant Grades (SEC EDGAR statements, EODHD prices and estimates); short interest: FINRA; earnings dates: earnings calendar; dividend yield: EODHD fundamentals · Quant run Nov 4, 2026
Grades rank each stock against its sector peers; they are not investment advice. How the rating and grades work · Short interest · Earnings calendar